Clinical experience in the treatment of hyperlipoproteinemia
Razboinikov, S.; Shipkov, T.
Vutreshni Bolesti 12(5): 114-121
1973
ISSN/ISBN: 0506-2772 PMID: 4782214 Document Number: 58792
Document emailed within 1 workday
Related Documents
Reuter, W. 1981: Clinical aspects of the problem of hyperlipoproteinemia and age Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 36(5): 141-145Widhalm, K. 1990: Dietary treatment of hyperlipoproteinemia Wiener Medizinische Wochenschrift 140(4): 88-93
Chibisov, I.V.; Karmanskiĭ, I.M. 1982: Hyperlipoproteinemia in glycogenosis and its treatment Pediatriia 2: 6-9
Ciświcka-Sznajderman, M. 1976: Pharmacological treatment of primary hyperlipoproteinemia Polski Tygodnik Lekarski 31(7): 289-291
Kłosiewicz-Latoszek, L. 1990: Principles of pharmacologic treatment for hyperlipoproteinemia Wiadomosci Lekarskie 43(15-16): 821-833
Dabels, J.; Rinke, E. 1977: The clinical significance of the risk factor hyperlipoproteinemia. Study on 2700 patients Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 32(13): 194-196
Manganelli, P.; Salaffi, F.; Ambanelli, U. 1989: Pseudo-Sjogren's syndrome in type IV hyperlipoproteinemia. Description of a clinical case Minerva Medica 80(9): 1031-1033
Bartz, V.T.; Gatz, J.; Slotty, C.; Schröter, C.; Töle, R.; Wand, P. 1993: Long-term treatment of hyperlipoproteinemia with etofibrate Fortschritte der Medizin 111(25): 398-400
Kleiber, G.; Leickert, K.H. 1979: Beta-pyridyl-carbinol in the treatment of hyperlipoproteinemia Zfa. Zeitschrift für Allgemeinmedizin 55(21): 1199-1205
Válek, J.; Jirkovská, A.; Grafnetter, D. 1991: Small doses of the resin Colestid in the treatment of hyperlipoproteinemia Casopis Lekaru Ceskych 130(6): 172-176
Mincou, I.; Străchinariu, R.; Georgesco, M. 1979: Specific treatment of primary hyperlipoproteinemia in diabetes mellitus Medecine Interne 17(2): 163-168
Oganov, R.G.; Gratsianskiĭ, N.A.; Mazur, N.A.; Lazebnik, L.B.; Belousov, I.B.; Sidorenko, B.A.; Ol'binskaia, L.I.; Vertkin, A.L.; Shevchenko, O.P.; Karpov, I.A. 1992: Circadian rhythm in the clinical course of cardiovascular diseases. Clinical experience using Norvasc (amlodipine) in the treatment of patients with ischemic heart disease and arterial hypertension Kardiologiia 32(5): 99-112
Jäger, E.; Sinzinger, H.; Widhalm, K.; Kaliman, J.; Höfer, R. 1982: Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis Wiener Klinische Wochenschrift 94(16): 421-425
Weisweiler, P. 1985: Dietary treatment of hyperlipoproteinemia. Reduction of atherogenic lipid fractions in normal subjects Fortschritte der Medizin 103(7): 148-150
Manojlović, D.; Lepsanović, L.; Micić, D.; Sumarac, M.; Kendereski, L.; Popović, V.; Mićić, J. 1991: Multicenter study of the efficacy and tolerance of gemfibrozil and fenofibrate in the treatment of primary hyperlipoproteinemia Srpski Arhiv Za Celokupno Lekarstvo 119(1-2): 22-25
Ivanova, I.L.; Ian'kova, V.I.; Knyshova, V.V.; Kozlovskaia, E.P. 2000: A specialized product with antioxidant action in the treatment of lipid disorders in experimental hyperlipoproteinemia Voprosy Pitaniia 69(1-2): 13-15
Falko, J.M.; Witztum, J.L.; Schonfeld, G.; Bateman, J. 1979: Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterol Annals of Internal Medicine 91(5): 750-751
Philpott, M.G. 1970: The treatment of enuresis; further clinical experience with imipramine British Journal of Clinical Practice 24(8): 327-329
Conzo, G.; Esposito, M.G.; Di Marzo, M.; Astarita, G.; Celsi, S. 2003: Treatment for microcarcinoma of the thyroid. Clinical experience Tumori 89(4 Suppl): 210-211
Tan, L.B.; Chiang, C.P.; Huang, C.H.; Chou, Y.H.; Wang, C.J.; Lou, L.H. 1989: Clinical experience of treatment of urethral stricture Gaoxiong Yi Xue Ke Xue Za Zhi 5(4): 201-205